Subscribe To
Johnson & johnson: supplemental bla of carvykti gives great growth opportunity
Johnson & Johnson's Supplemental Biologics Licensing Application of CARVYKTI was filed; approval would allow company to target a much earlier Multiple...
July 6, 2023, 2:48 pm
Iag share price technical analysis: worrying pattern forms
IAG (LON: IAG) share price has been in a slow recovery mode in the past few weeks as investors assess the recovery of the aviation sector. The stock j...
July 6, 2023, 2:00 pm
Uranium stocks are looking attractive again as nuclear demand poised to power up
Uranium supply will need to increase significantly to meet the market's needs if nuclear is to become a key source of energy in the global push to red...
July 6, 2023, 1:25 pm
Here's why novocure stock dropped 42% in june
Novocure published the results of an important phase 3 clinical trial last month. The treatment clearly demonstrated strong results that improved outc...
July 6, 2023, 1:17 pm
New york's minimum wage law sends shockwaves through gig economy
Uber and DoorDash face significant operational challenges as New York City's new minimum wage law, tripling base pay for gig workers, threatens to dis...
July 6, 2023, 1:11 pm
Vertex (vrtx) gets nod in eu for orkambi expanded indication
Vertex's (VRTX) Orkambi gets approval from the European Commission in the EU for the treatment of cystic fibrosis in ...
July 6, 2023, 12:20 pm
Intel: a turnaround play
Intel aims to become the second-largest external foundry by 2030, promising to deliver five new nodes in four years. CEO ...
July 6, 2023, 11:59 am
Uber rival bolt moves closer to ipo, brings on new cfo
Bolt, an Estonian ride-sharing and food and grocery delivery company, has appointed Mikko Salovaara as its new chief financial officer ahead of its an...
July 6, 2023, 11:46 am
Lockheed (lmt) secures contract to aid f-16 jet program
Lockheed (LMT) is set to provide F-16 Peace Carpathian M6.6 Operational Flight Program and System upgra...
July 6, 2023, 11:35 am
Onto innovation to report second quarter 2023 financial results on august 10, 2023
WILMINGTON, Mass.--(BUSINESS WIRE)---- $ONTO--Onto Innovation Inc. (NYSE: ONTO) will release its 2023 second quarter results shortly after the market ...
July 6, 2023, 10:21 am
patterson-uti (pten) to buy ulterra, strengthen portfolio
The acquisition of Ulterra will expand patterson-UTI's (PTEN) operational and technology portfolio, str...
July 6, 2023, 10:06 am
Amazon falls to test support in this pattern: the bull, bear case for the stock - amazon.com (nasdaq:amzn)
Amazon.com, Inc AMZN was down about 2% on Thursday morning, at the lower trend line of a rising channel pat...
July 6, 2023, 10:05 am
Investors heavily search uipath, inc. (path): here is what you need to know
Uipath (patH) has received quite a bit of attention from...
July 6, 2023, 10:05 am
Kinross (kgc) closes $500m unsecured 10-year notes offering
Kinross (KGC) anticipates redeeming the entire principal amount of its outstanding 5.95% senior notes d...
July 6, 2023, 8:35 am
Aslan pharmaceuticals shares slide amid new data on atopic dermatitis treatment
Shares of Aslan Pharmaceuticals ASLN were down 32% premarket on Thursday after the company released new data from a clinical study of eblasakimab, an ...
July 6, 2023, 8:22 am
News spat escalates between facebook parent meta and canada
The Canadian government's decision to suspend advertising on Facebook and Instagram marks a new escalation in the ongoing rift between the social medi...
July 6, 2023, 8:21 am
Healthpeak properties is a bargain around its 14-year lows
Healthpeak Properties has underperformed the Real Estate Select Sector SPDR ETF this year, declining by 18% due to a delay in its pandemic recovery. D...
July 6, 2023, 8:15 am
Cult food science reveals independent laboratory testing results for its cultivated pet food ingredient
CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) said that independent laboratory testing conducted on its innovative cultivated pet food ingredient, ...
July 6, 2023, 8:13 am
Revive therapeutics' study on safety and efficacy of bucillamine to treat covid 19 shows no statistical significance
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said the results of its Phase 3 clinical trial evaluating the safety and efficacy of oral Bucillamine i...
July 6, 2023, 8:07 am
Wall street is cautious on these 2 first half winners
Lately, it seems like the only thing that can stop the U.S. equity markets is a holiday early close. Heading into the 4th of July celebration, major s...
July 6, 2023, 7:11 am